Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Christine Brefel-Courbon »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Christine Brefel < Christine Brefel-Courbon < Christine Coubes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000014 (2015) Isabelle Rieu [France] ; Pablo Martinez-Martin ; Bruno Pereira ; Ingrid De Chazeron ; Leo Verhagen Metman ; Marjan Jahanshahi ; Claire Ardouin ; Isabelle Chéreau ; Christine Brefel-Courbon ; Fabienne Ory-Magne ; Helene Klinger ; Fleur Peyrol ; Michael Schupbach ; Kathy Dujardin ; François Tison ; Jean Luc Houeto ; Paul Krack ; Franck DurifInternational validation of a behavioral scale in Parkinson's disease without dementia.
000179 (2011) Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France]Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
000206 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
000262 (2009) Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Sabrina Debruxelles [France] ; Igor Sibon [France] ; Cyril Goizet [France] ; Pierre Labauge [France] ; Patrice Menegon [France] ; Emmanuelle Uro-Coste [France] ; Bernardino Ghetti [États-Unis] ; Marie Bernadetle Delisle [France] ; Ruben Vidal [États-Unis] ; Olivier Rascol [France]Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498‐499InsTC)
000270 (2009) Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Sabrina Debruxelles [France] ; Igor Sibon [France] ; Cyril Goizet [France] ; Pierre Labauge [France] ; Patrice Menegon [France] ; Emmanuelle Uro-Coste [France] ; Bernardino Ghetti [États-Unis] ; Marie Bernadetle Delisle [France] ; Ruben Vidal [États-Unis] ; Olivier Rascol [France]Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)
000339 (2007) Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France]Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
000351 (2007) Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France]Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
000407 (2005) Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; François Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France]Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
000421 (2005) Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; Francois Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France]Effect of levodopa on pain threshold in Parkinson's disease : A clinical and positron emission tomography study
000438 (2004) Pierre Payoux [France] ; Kader Boulanouar [France] ; Christine Sarramon [France] ; Nelly Fabre [France] ; Sylvie Descombes [France] ; Monique Galitsky [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Umberto Sabatini [Italie] ; Claude Manelfe [France] ; François Chollet [France] ; Laurent Schmitt [France] ; Olivier Rascol [France]Cortical motor activation in akinetic schizophrenic patients: A pilot functional MRI study
000457 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
000458 (2003) Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
000463 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
000508 (2001) Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
000569 (1998) Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni]Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy

List of associated KwdEn.i

Nombre de
documents
Descripteur
10Humans
7Male
7Middle Aged
7Parkinson disease
6Aged
6Female
6Nervous system diseases
6Parkinson's disease
5Adult
4Parkinson Disease (drug therapy)
3Antiparkinson Agents (therapeutic use)
3Cross-Over Studies
3Double-Blind Method
3Human
3Prospective Studies
3Severity of Illness Index
3Treatment Outcome
2Antiparkinson Agents (administration & dosage)
2Brain Mapping
2Clinical trial
2Dose-Response Relationship, Drug
2Emission tomography
2France (epidemiology)
2Levodopa
2Levodopa (therapeutic use)
2Magnetic Resonance Imaging
2Pain
2Pain Threshold (drug effects)
2Parkinson Disease (complications)
2Parkinson Disease (therapy)
2Phenotype
2Pilot Projects
2Positron emission tomography
2Positron-Emission Tomography
2Quality of Life
2apomorphine
2levodopa
2pain threshold
13-Iodobenzylguanidine (diagnostic use)
13-Iodobenzylguanidine (pharmacokinetics)
1Administration, Sublingual
1Adrenergic alpha-Antagonists (adverse effects)
1Adrenergic alpha-Antagonists (therapeutic use)
1Age of Onset
1Ageing
1Aging
1Alpha‐2 antagonist
1Antiparkinson Agents (pharmacology)
1Antiparkinson agent
1Apoferritins (genetics)
1Apomorphine (administration & dosage)
1Apomorphine (pharmacology)
1Apomorphine (therapeutic use)
1Autonomic Nervous System Diseases (complications)
1Autonomic Nervous System Diseases (diagnosis)
1Autonomic Nervous System Diseases (physiopathology)
1Balneology (economics)
1Balneology (methods)
1Basal Ganglia Diseases (genetics)
1Basal Ganglia Diseases (metabolism)
1Basal Ganglia Diseases (pathology)
1Basal Ganglia Diseases (radionuclide imaging)
1Basal ganglion
1Benzofurans (adverse effects)
1Benzofurans (therapeutic use)
1Bromocriptine
1Bromocriptine (administration & dosage)
1Bromocriptine (therapeutic use)
1Case-Control Studies
1Central Nervous System (chemistry)
1Central Nervous System (pathology)
1Cerebellar Ataxia (genetics)
1Cerebellar Ataxia (metabolism)
1Cerebellar Ataxia (pathology)
1Cerebellar Ataxia (radionuclide imaging)
1Cerebral Cortex (blood supply)
1Cerebral Cortex (radionuclide imaging)
1Cerebrovascular Circulation (drug effects)
1Chemotherapy
1Complication
1Cost-Benefit Analysis
1Deep Brain Stimulation (methods)
1Deep brain stimulation
1Dementia (genetics)
1Dementia (metabolism)
1Dementia (pathology)
1Dementia (radionuclide imaging)
1Denervation
1Differential diagnostic
1Diseases of the autonomic nervous system
1Dominance, Cerebral (physiology)
1Dopamine agonist
1Double blind study
1Drug Administration Routes
1Drug Administration Schedule
1Drug Therapy, Combination
1Economic analysis
1Efaroxan
1Ergot derivatives
1Ferritin

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Christine Brefel-Courbon" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Christine Brefel-Courbon" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Christine Brefel-Courbon
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024